Audentes Therapeutics: 3Q Earnings Snapshot

November 6, 2018

SAN FRANCISCO (AP) _ Audentes Therapeutics Inc. (BOLD) on Tuesday reported a loss of $36.3 million in its third quarter.

The San Francisco-based company said it had a loss of 97 cents per share.

The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 88 cents per share.

Audentes Therapeutics shares have dropped slightly more than 5 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $29.56, a rise of 17 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BOLD at https://www.zacks.com/ap/BOLD

Update hourly